Get the Stockscreener App
3.02
5.03%
-0.16
Ispecimen Inc stock is traded at $3.02, with a volume of 54,265.
It is down -5.03% in the last 24 hours and down -49.07% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$3.18
Open:
$3.11
24h Volume:
54,265
Relative Volume:
0.06
Market Cap:
$4.34M
Revenue:
$1.93M
Net Income/Loss:
$-10.49M
P/E Ratio:
-0.0343
EPS:
-87.9728
Net Cash Flow:
$-5.24M
1W Performance:
-4.43%
1M Performance:
-49.07%
6M Performance:
-84.38%
1Y Performance:
-94.01%
1-Day Range:
$3.00
$3.12
1-Week Range:
$2.90
$3.35
52-Week Range:
$2.90
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
3.02 | 4.57M | 1.93M | -10.49M | -5.24M | -87.97 |
TMO
Thermo Fisher Scientific Inc
|
472.80 | 179.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
184.30 | 132.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
562.16 | 44.55B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.44 | 39.08B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
365.36 | 36.96B | 3.77B | 449.25M | 240.68M | 7.8556 |
Ispecimen Inc Stock (ISPC) Latest News
iSpecimen (NASDAQ: ISPC) registers 488,290 shares from May 2026 placement - Stock Titan
MSN Money - MSN
$iSpecimen (ISPC.US)$ so far so good - Moomoo
iSpecimen Receives Nasdaq Noncompliance Notice, Listing at Risk - The Globe and Mail
iSpecimen Inc. Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Emerging Growth Status (May 29, 2026) - Minichart
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (NASDAQ: ISPC) falls below Nasdaq equity listing requirement - Stock Titan
iSpecimen Inc. Files Form 8-K Announcing Approval of 2025 Stock Incentive Plan and Key Company Details - Minichart
What's Driving iSpecimen's Recent Stock Surge - Kavout
iSpecimen Shareholders Approve Director, Auditor and Incentive Plan - TipRanks
iSpecimen (ISPC) investors approve director, auditor and 2025 stock incentive plan - Stock Titan
iSpecimen trades near lows as cash test and vote loom - Bez Kabli
iSpecimen Inc. (ISPC) Holds Steady Near Key Support as Sector Headwinds LingerMean Reversion Trade - thelegaladvocate.com
iSpecimen Inc. (ISPC) Slips 2% as Stock Tests Support Near $3.21Swing Trade Setups - newsline.com
iSpecimen Inc (ISPC) Stock Price, Quote, News & History - Benzinga
iSpecimen (ISPC) Q3 2024 Earnings: Disappointing Bottom Line Sends Shares LowerDownward Estimate Revision - newsline.com
iSpecimen stock (US46536T1016): Company update still needs a dated catalyst - AD HOC NEWS
iSpecimen Inc stock (US46536T1016): Clinical sample platform faces a fresh investor spotlight - AD HOC NEWS
iSpecimen Inc. Q1 2026 10-Q Report: Financial Performance, Going Concern, and Reverse Stock Split Overview - Minichart
iSpecimen Inc. 1Q 2026: Revenue $156.01K, EPS ($6.66) — 10-Q Summary - TradingView
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
What is iSpecimen Inc. stock? - Bitget
iSpecimen (NASDAQ: ISPC) posts Q1 2026 loss and warns of going-concern risk - Stock Titan
iSpecimen (NASDAQ: ISPC) notifies SEC of late 10-Q filing - Stock Titan
ISPC Should I Buy - Intellectia AI
iSpecimen stock (US46536T1016): capital raise and Nasdaq compliance in focus - AD HOC NEWS
iSpecimen Inc. Announces $2.5 Million Private Placement to Support Marketplace Growth and Marketing Efforts - Minichart
iSpecimen Regains Nasdaq Compliance and Raises New Capital - TipRanks
iSpecimen Raises ~$2.5 Million via Private Placement of Stock and Pre-Funded Warrants - TradingView
iSpecimen (Nasdaq: ISPC) prices $2.5M private placement and regains Nasdaq bid compliance - Stock Titan
iSpecimen raises $2.5M in private placement via E.F. Hutton By Investing.com - Investing.com South Africa
iSpecimen raises $2.5M in private placement via E.F. Hutton - Investing.com
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement - The Manila Times
E.F. Hutton Secures $2.5 Million for iSpecimen - Intellectia AI
TradingKey - TradingKey
iSpecimen announces pricing of approximately $2.5M private placement - MSN
ISpecimen Inc. announced that it has received $2.500004 million in funding - marketscreener.com
iSpecimen prices $2.5M private placement at $5.12 per share By Investing.com - Investing.com Australia
iSpecimen Completes $2.5 Million Private Placement - Intellectia AI
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement - Taiwan News
ISPCiSpecimen Inc. stock news, filings & ratings - Quantisnow
In $2.5M financing, iSpecimen earmarks up to $900,000 for marketing - Stock Titan
iSpecimen Announces $2.5 Million Private Placement Priced at $1.10 Per Share - geneonline.com
iSpecimen prices $2.5M private placement at $5.12 per share - Investing.com
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.13%
2.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):